1. How to Protect Ovarian Function before and during Chemotherapy?
   Luca Arecco et al, 2021, Journal of Clinical Medicine CrossRef
2. Primary Ovarian Insufficiency
   Agnieszka Podfigurna et al, 2017, Menopause CrossRef
3. Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons
   Marie-Madeleine Dolmans et al, 2020, Fertility and Sterility CrossRef
4. Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial
   José M. Gris-Martínez et al, 2016, Medicina Clínica (English Edition) CrossRef
5. Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity
   Shun-Jen Tan et al, 2014, Reproductive BioMedicine Online CrossRef
6. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists
   Lisa C. Hickman et al, 2018, Journal of Assisted Reproduction and Genetics CrossRef
7. Use of GnRH Analogs for Prevention of Chemotherapy-Induced Gonadotoxicity
   Matteo Lambertini et al, 2021, Fertility Preservation CrossRef
8. The possibility of dexrazoxane to prevent ovarian damage caused by toxicity
   Jenna Kropp et al, 2016, Expert Review of Quality of Life in Cancer Care CrossRef
9. Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists
   Sandro Barni et al, 2015, Future Oncology CrossRef
10. Cancer and fertility preservation: international recommendations from an expert meeting
    Matteo Lambertini et al, 2016, BMC Medicine CrossRef
11. Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
    Matteo Lambertini et al, 2019, Clinical Medicine Insights: Reproductive Health CrossRef
12. Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI)
    Bunpei Ishizuka, 2021, Frontiers in Endocrinology CrossRef
13. Efecto protector de los análogos de la GnRH sobre la capacidad reproductiva de las mujeres en edad fértil con neoplasia o enfermedad autoinmunitaria tratadas con fármacos citotóxicos. Resultado final de un ensayo clínico fase II
    José M. Gris-Martínez et al, 2016, Medicina Clínica CrossRef
14. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application
    Matteo Lambertini et al, 2019, Cancer Treatment Reviews CrossRef
15. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists
    Lisa C. Hickman et al, 2016, American Journal of Obstetrics and Gynecology CrossRef
16. Premature ovarian insufficiency: the context of long-term effects
    A. Podfigurna-Stopa et al, 2016, Journal of Endocrinological Investigation CrossRef
17. Hormonal Suppression for Ovarian Protection
    Eva Blondeaux et al, 2022, Female and Male Fertility Preservation CrossRef